ストックスクリーナーアプリを入手
0.00
100.00%
-47.98
前日終値:
$47.98
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$1.23B
収益：
-
当期純損益:
$11.77M
株価収益率:
0.00
EPS:
0.5785
ネットキャッシュフロー:
$-19.23M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$48.27
Tourmaline Bio Inc Stock (TRML) Company Profile
TRML を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
0.00 | 1.23B | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-23 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-06 | 開始されました | Wedbush | Outperform |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-12-15 | 開始されました | Jefferies | Buy |
| 2023-12-04 | 再開されました | H.C. Wainwright | Buy |
| 2023-11-17 | 開始されました | Truist | Buy |
| 2023-10-31 | 開始されました | Guggenheim | Buy |
| 2023-10-25 | 開始されました | Piper Sandler | Overweight |
| 2022-10-20 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
すべてを表示
Tourmaline Bio Inc (TRML) 最新ニュース
Movement Recap: What catalysts could drive Tourmaline Bio Inc stock higherRate Cut & Precise Buy Zone Tips - BỘ NỘI VỤ
Can Tourmaline Bio Inc. stock outperform in 2025 bull marketEarnings Risk Summary & Daily Stock Trend Watchlist - moha.gov.vn
Will Tourmaline Bio Inc. stock outperform value stocksQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Is Tourmaline Bio Inc. stock attractive after correctionTrade Entry Summary & Verified Short-Term Plans - newser.com
How to manage a losing position in Tourmaline Bio Inc.Market Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Will Tourmaline Bio Inc. stock reach all time highs in 2025Trade Performance Summary & Safe Swing Trade Setups - newser.com
Combining machine learning predictions for Tourmaline Bio Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
How Tourmaline Bio Inc. stock performs in rate cut cyclesJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Is Tourmaline Bio Inc. stock a top pick in earnings seasonAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
[EFFECT] Tourmaline Bio, Inc. SEC Filing - Stock Titan
Using Bollinger Bands to evaluate Tourmaline Bio Inc.Portfolio Gains Report & Daily Technical Forecast Reports - newser.com
Tourmaline Bio Inc. recovery potential after sell offPortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com
How institutional buying supports Tourmaline Bio Inc. stockJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - Fundação Cultural do Pará
How to monitor Tourmaline Bio Inc. with trend dashboardsQuarterly Profit Review & Step-by-Step Swing Trade Plans - newser.com
Analyzing drawdowns of Tourmaline Bio Inc. with statistical toolsJobs Report & Precise Swing Trade Alerts - newser.com
Tourmaline Bio Inc.’s volatility index tracking explainedAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
Statistical indicators supporting Tourmaline Bio Inc.’s strength2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Is Tourmaline Bio Inc. stock a smart buy before Fed meeting2025 Volatility Report & Real-Time Market Trend Scan - newser.com
Tourmaline Bio Inc (TRML) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):